MILESTONE PHARMACEUTICALS INC. THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT Dated as of October 15, 2018Registration Rights Agreement • April 12th, 2019 • Milestone Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledApril 12th, 2019 Company IndustryTHIS THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT is made as of October 15, 2018 between Milestone Pharmaceuticals Inc. (the “Corporation”), a legal person existing under the laws of the Province of Québec, represented herein by Joseph Oliveto, its Chief Executive Officer, duly authorized for the purposes hereof as he so declares, and the holders of Class A Preferred Shares, the holders of Class B Preferred Shares, the holders of Class C Preferred Shares and the holders of Class D Preferred Shares of the Corporation listed on Schedule A, as such Schedule may be amended from time to time (collectively, the “Investors”).
MILESTONE PHARMACEUTICALS INC. THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT Dated as of October 15, 2018Registration Rights Agreement • December 21st, 2018 • Milestone Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledDecember 21st, 2018 Company IndustryTHIS THIRD AMENDED & RESTATED REGISTRATION RIGHTS AGREEMENT is made as of October 15, 2018 between Milestone Pharmaceuticals Inc. (the “Corporation”), a legal person existing under the laws of the Province of Québec, represented herein by Joseph Oliveto, its Chief Executive Officer, duly authorized for the purposes hereof as he so declares, and the holders of Class A Preferred Shares, the holders of Class B Preferred Shares, the holders of Class C Preferred Shares and the holders of Class D Preferred Shares of the Corporation listed on Schedule A, as such Schedule may be amended from time to time (collectively, the “Investors”).